{
    "clinical_study": {
        "@rank": "42131", 
        "brief_summary": {
            "textblock": "This study is to evaluate the effects (good and bad) of ALIMTA and Cisplatin or ALIMTA alone\n      on you and your malignant pleural mesothelioma as well as make ALIMTA available to patients\n      who qualify for treatment."
        }, 
        "brief_title": "ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.", 
        "condition": "Mesothelioma", 
        "condition_browse": {
            "mesh_term": "Mesothelioma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Have a proven diagnosis of malignant mesothelioma in patients not candidates for\n             curative surgery\n\n          -  Prior chemotherapy for your disease is allowed\n\n          -  Measurable lesion is not required\n\n          -  Have a adequate performance status\n\n          -  Sign an informed consent form\n\n        Exclusion Criteria:\n\n          -  You are excluded from this trial if you have received any investigational agent\n             within 4 week before enrolling in this study\n\n          -  You are excluded from this trial if you have received radiation within the previous 2\n             weeks\n\n          -  You are excluded from this trial if you are a candidates for curative surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "July 2, 2002", 
        "id_info": {
            "nct_id": "NCT00040625", 
            "org_study_id": "6093", 
            "secondary_id": "H3E-US-JMFE"
        }, 
        "intervention": [
            {
                "intervention_name": "Pemetrexed", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Cisplatin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Pemetrexed", 
                "Cisplatin"
            ]
        }, 
        "lastchanged_date": "March 14, 2007", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Basking Ridge", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto Alegre", 
                        "country": "Brazil", 
                        "state": "RS"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "\"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician.\""
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jeddah", 
                        "country": "Saudi Arabia"
                    }, 
                    "name": "For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Brazil", 
                "Egypt", 
                "Saudi Arabia"
            ]
        }, 
        "overall_status": "Approved for marketing", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00040625"
        }, 
        "source": "Eli Lilly and Company", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Eli Lilly and Company", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Expanded Access", 
        "verification_date": "March 2007"
    }, 
    "geocoordinates": {
        "\"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician.\"": "30.044 31.236", 
        "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.": "40.706 -74.549", 
        "For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician": "21.543 39.173"
    }
}